The reaction engineering of benzaldehyde lyase (BAL, E.C. 4.1.2.38) from Pseudomonas fluorescens catalyzing the enantioselective carboligation of benzaldehyde and acetaldehyde yielding ( R )-2-hydroxy-1-phenylpropanone (HPP) is presented. Based on kinetic studies a continuous process is developed. The developed bioreactor allows focusing the complex reaction system on the production of HPP with simultaneous discrimination of the undesired benzoin formation. The application of a continuous process in combination with membrane technology enables high space time yields (1120 g L - 1 d - 1, ee > 99%) of the product as well as high total turnover numbers of the biocatalyst (mol of product/mol of biocatalyst = 188.000). A kinetic model was developed to simulate the continuously operated reactor and to determine optimal production conditions. The synthesis of ( R )-(3-chlorophenyl)-2-hydroxy-1-propanone (1214 g L - 1 d - 1, ee = 99%) in the bioreactor demonstrates a broad applicability of the presented reactor concept for the production HPP derivatives.
No takes yet. Share an insight, caveat, or question.
Stillger et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: